MassMutual Private Wealth & Trust FSB Sells 990 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

MassMutual Private Wealth & Trust FSB trimmed its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 8.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,239 shares of the company’s stock after selling 990 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Inspire Medical Systems were worth $1,898,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Merit Financial Group LLC bought a new position in Inspire Medical Systems in the fourth quarter valued at about $313,000. Pallas Capital Advisors LLC grew its holdings in shares of Inspire Medical Systems by 6.1% during the 4th quarter. Pallas Capital Advisors LLC now owns 4,037 shares of the company’s stock valued at $748,000 after purchasing an additional 233 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in Inspire Medical Systems by 1.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock worth $1,461,000 after purchasing an additional 79 shares in the last quarter. Diversified Trust Co lifted its stake in Inspire Medical Systems by 3.8% in the 4th quarter. Diversified Trust Co now owns 4,686 shares of the company’s stock valued at $869,000 after purchasing an additional 173 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in Inspire Medical Systems by 3,812.6% in the 3rd quarter. Principal Financial Group Inc. now owns 141,089 shares of the company’s stock valued at $29,777,000 after purchasing an additional 137,483 shares during the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Inspire Medical Systems Price Performance

Shares of NYSE:INSP opened at $177.97 on Tuesday. The business’s 50-day moving average is $189.18 and its 200-day moving average is $185.41. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The company has a market capitalization of $5.33 billion, a price-to-earnings ratio of 166.33 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. During the same period last year, the business posted ($0.29) EPS. The firm’s revenue for the quarter was up 32.6% compared to the same quarter last year. Analysts anticipate that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on INSP. Piper Sandler reissued an “overweight” rating and set a $260.00 price target (up from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Robert W. Baird boosted their target price on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a report on Tuesday, November 5th. Wells Fargo & Company raised their price target on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Stifel Nicolaus reissued a “hold” rating and issued a $200.00 price objective (up previously from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Finally, Truist Financial reaffirmed a “buy” rating and set a $240.00 target price (up from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $232.55.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.